Innodata
Builds training data, evaluations, safety programs, and deployment workflows for advanced AI systems.
Something off on this page? Send us feedback.
Profile
Develops training and post-training data, model evaluations, safety programs, and deployment workflows for AI builders and enterprise adopters, supplemented by Synodex healthcare-data and Agility media-intelligence software. Revenue comes primarily from project-based services for U.S. customers and is concentrated in two large accounts.
Builds training and post-training datasets, model evaluations, alignment and safety programs, and deployment workflows for advanced AI systems. Synodex turns medical records into structured data for insurance and healthcare processes, while Agility supplies media intelligence and public-relations workflow software. These offerings now sit within one reportable segment.
Combines proprietary workflow tools, automation, quality controls, and specialist human judgment to run repeatable data and evaluation programs. Delivery uses a globally distributed workforce across Asia, North America, and Europe, while customers are predominantly in the United States. Revenue is concentrated in two large customers, and project-based agreements generally provide no committed future volume and can be terminated on short notice.
Company facts
Key statistics
Year to date +6.8% · Average volume (30d) 1.4M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Wedbush | Reiterate | Outperform | $90 | $120 | |
| Jan 5, 2026 | BWS Financial | Upgrade | Buy | Top Pick | ||
| Oct 15, 2025 | Wedbush | Reiterate | Outperform | $48 | $90 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026Q2 FY26 | $0.21 | $0.41 | +92.5% | $86.3M | $92.1M | +6.8% | −4.81% |
| May 7, 2026Q1 FY26 | $0.13 | $0.42 | +223.1% | $76.5M | $90.1M | +17.8% | +86.00% |
| Feb 26, 2026Q4 FY25 | $0.21 | $0.25 | +19.0% | $69.5M | $72.4M | +4.2% | −7.17% |
| Nov 6, 2025Q3 FY25 | $0.14 | $0.24 | +71.4% | $69.5M | $62.6M | −10.0% | +6.90% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $58.3M | $58.4M | $62.6M | $72.4M | $90.1M | $92.1M | |
| Gross profit | $23.3M | $23.2M | $25.9M | $27.8M | $39.1M | $42.5M | |
| Operating income | $8.3M | $9.1M | $10.8M | $11.0M | $16.2M | $15.9M | |
| Net income | $7.8M | $7.2M | $8.3M | $8.8M | $14.9M | $14.4M | |
| Diluted EPS | $0.22 | $0.20 | $0.24 | $0.25 | $0.42 | $0.41 | |
| Gross margin | 39.9% | 39.8% | 41.4% | 38.3% | 43.4% | 46.1% | |
| Operating margin | 14.2% | 15.6% | 17.2% | 15.2% | 18.0% | 17.2% |
Fiscal years (4-quarter sums)FY21 $69.8M · FY22 $79.0M · FY23 $86.8M · FY24 $170.5M · FY25 $251.7M
Revenue by product · Q2 FY26
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $250.4M · Total debt $15.0M · Total assets $356.7M · Shareholders' equity $159.5M
Dividends
No dividends on record.
Ownership
Shares outstanding 32.66M · Float 31.00M · 94.9% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 2.72M | 8.32% | 13F | Aug 7, 2026 |
| Vanguard Capital Management | 1.63M | 5.00% | 13G | Jul 31, 2026 |
| Jack Abuhoff · director, officer: CEO | 1.34M | 4.10% | Form 4 | Jun 16, 2026 |
| Jane Street Group, LLC | 1.27M | 3.90% | 13F | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | 878.8K | 2.69% | 13F | Aug 14, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 15, 2026 | Jack Abuhoff | director, officer: CEO | −94,059 | $105.70 |
| Jun 16, 2026 | Jack Abuhoff | director, officer: CEO | −200,000 | $110.20 |
| Jun 2, 2026 | Ashok Mishra | officer: EVP and COO | −38,666 | $114.34 |
| May 29, 2026 | Jack Abuhoff | director, officer: CEO | −105,586 | $103.50 |
| May 29, 2026 | Marissa B. Espineli | officer: Interim CFO | −19,667 | $105.88 |
Peers
- TaskUs
AI services and trust operations overlap with DDS workflows
- TELUS
Owned TELUS Digital overlaps in AI data, CX, and trust operations
- ExlService
Data, AI, and digital operations overlap in insurance and healthcare
- Sprinklr
AI-native social listening and media intelligence overlap
- Quest Diagnostics
ExamOne overlaps in life-insurance health data workflows
- RELX (ADR)
Insurance risk analytics overlap with Synodex-adjacent data work
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Innodata | $56.60 | +0.02% | $1.85B | 42.9 | 51.9 | 5.8 | +57.8% |
| TaskUs | $8.59 | +2.23% | $756.9M | 7.3 | 6.1 | 0.6 | +5.0% |
| TELUS | $9.75 | +0.72% | $15.10B | — | 25.6 | 1.0 | −6.0% |
| ExlService | $38.40 | 0.00% | $5.82B | 24.2 | 16.1 | 2.6 | +15.6% |
| Sprinklr | $8.00 | −2.08% | $2.01B | 72.9 | 16.3 | 2.3 | +6.8% |
| Quest Diagnostics | $244.50 | +0.69% | $26.79B | 25.8 | 21.2 | 2.3 | +10.2% |
| RELX (ADR) | $36.54 | 0.00% | $63.79B | 21.3 | — | 4.8 | +0.4% |
| Median | 24.2 | 16.3 | 2.3 | +5.9% |









